TIPE3 and non-small cell lung carcinoma: Collectively, we provide evidences that human TIPE3 promotes the growth and migration of NSCLC cells depending on its localization in plasma membrane, whereas cytoplasmic TIPE3 exerts a negative function, thereby proposing TIPE3 as a potential target for NSCLC therapy.